| |
| |
|
| Insider
Information: |
Clyburn Frank |
| Relationship: |
Chief Executive Officer |
| City: |
Kenilworth |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
106,976 |
|
|
Indirect Shares
|
1,780 |
|
|
| Direct
Value |
$13,093,232 |
|
|
|
Indirect Value
|
$232,682 |
|
|
| Total
Shares |
108,756 |
|
|
| Total
Value |
$13,325,914 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 1.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merck & Co Inc |
MRK |
EVP & Pres ? Human Hea... |
2021-11-01 |
97,095 |
2021-11-01 |
1,780 |
Premium* |
|
|
Dowdupont Inc. |
DWDP |
Director |
2021-04-28 |
8,034 |
2019-06-03 |
0 |
Premium* |
|
|
International Flavors & Fragranc... |
IFF |
Chief Executive Officer |
2024-03-01 |
1,847 |
2023-03-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IFF |
International Flavors & F... |
Chief Executive Officer |
• • – |
2024-03-01 |
4 |
D |
$75.88 |
$24,509 |
D/D |
(323) |
1,847 |
0 |
- |
|
| IFF |
International Flavors & F... |
Chief Executive Officer |
• • – |
2024-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,324 |
2,170 |
0 |
- |
|
| IFF |
International Flavors & F... |
Chief Executive Officer |
• • – |
2023-03-01 |
4 |
D |
$91.64 |
$43,712 |
D/D |
(477) |
846 |
0 |
- |
|
| IFF |
International Flavors & F... |
Chief Executive Officer |
• • – |
2023-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,323 |
1,323 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP & Pres ? Human Health |
• • – |
2021-11-01 |
4 |
S |
$87.87 |
$3,493,879 |
D/D |
(39,762) |
97,095 |
0 |
% |
|
| MRK |
Merck & Co Inc |
EVP & Pres ? Human Health |
• • – |
2021-11-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
39,762 |
136,857 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP & Pres ? Human Health |
• • – |
2021-10-30 |
4 |
D |
$88.05 |
$102,314 |
D/D |
(1,162) |
97,095 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP & Pres ? Human Health |
• • – |
2021-10-30 |
4 |
OE |
$88.05 |
$207,622 |
D/D |
2,358 |
98,257 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP & Pres ? Human Health |
• • – |
2021-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,324 |
113,672 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP & Pres ? Human Health |
• • – |
2021-05-10 |
4 |
S |
$78.32 |
$1,513,440 |
D/D |
(19,324) |
94,348 |
0 |
% |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2021-05-04 |
4 |
D |
$75.98 |
$71,345 |
D/D |
(939) |
94,348 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2021-05-04 |
4 |
OE |
$75.98 |
$144,818 |
D/D |
1,906 |
95,287 |
0 |
- |
|
| DWDP |
Dowdupont Inc. |
Director |
– • – |
2021-04-28 |
4 |
A |
$77.05 |
$170,049 |
D/D |
2,207 |
8,034 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2021-02-26 |
4 |
A |
$72.62 |
$684,952 |
D/D |
9,432 |
92,589 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-10-30 |
4 |
D |
$75.89 |
$86,287 |
D/D |
(1,137) |
82,519 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-10-30 |
4 |
OE |
$75.89 |
$173,560 |
D/D |
2,287 |
83,656 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-08-05 |
4 |
S |
$81.55 |
$1,539,274 |
D/D |
(18,876) |
80,763 |
0 |
% |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-08-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,876 |
99,639 |
0 |
- |
|
| DWDP |
Dowdupont Inc. |
Director |
– • – |
2020-05-27 |
4 |
A |
$49.46 |
$170,043 |
D/D |
3,438 |
5,717 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-05-05 |
4 |
D |
$76.86 |
$142,037 |
D/D |
(1,848) |
80,763 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-05-05 |
4 |
OE |
$76.86 |
$288,379 |
D/D |
3,752 |
82,611 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-05-04 |
4 |
D |
$77.67 |
$72,854 |
D/D |
(938) |
78,859 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-05-04 |
4 |
OE |
$77.67 |
$147,884 |
D/D |
1,904 |
79,797 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2020-02-28 |
4 |
A |
$76.56 |
$375,527 |
D/D |
4,905 |
77,298 |
0 |
- |
|
| MRK |
Merck & Co Inc |
EVP, Chief Commercial Officer |
• • – |
2019-10-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,287 |
73,032 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
